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ABSTRACT

A method detects binding of molecules, advantageously
without tagging molecules in the sample. Asensor is used in
which is included a single stranded nucleic acid sequence
and a photoluminescent material in respective layers. After
the sensor is exposed to a biological sample for sufficient
time for its single stranded nucleic acid sequence to bind to
a material of interest, photoluminescence from the sensor
can be measured. An apparatus for tagging-free detection of
binding of molecules also is provided. Methods of making
tagging-free sensors are provided. Also, tagging-free methods to detect binding of antigens and related devices are
disclosed.
22 Claims, 14 Drawing Sheets
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functional study (such as mutation, gene expression) of
genetic code, understanding various biological mechanisms,
crime detection, etc. Although advances in DNA sequencing
and other protein sequencing technologies have been made
s in recent years, such procedures still limit and delay workers
in the art awaiting sequencing results. Those whose work
relies on DNA sequencing and other protein sequencing
This application claims the benefit of provision applicawould be helped by expedited rapidity of sequencing, simtions Nos. 601286,525 filed Apr. 27, 2001 and 601237,677
plified sequencing, andlor enhanced precision and accuracy.
filed Oct. 5, 2000.
10 Also, a small portable device useable in a doctor's office to
FIELD OF THE INVENTION
check, for example, if a patient may eventually develop
cancer
Or how fast the
is likely to break down a 'pecific
The invention generally relates to nucleic acid, and more
anti-cancer drug have been generally theorized as of interest.
particularly, to binding of single stranded nucleic acid with
For all these applications, a tool that can perform a nucleic
biological material of interest in a sample to identify the
IS acid analysis of a small size sample for several specific
material.
genes (at low concentrations) is highly desirable, but not
conventionally. provided. Rather, the conventional bio-chip
BACKGROUND OF THE INVENTION
methods undesirably require tagging of the sample plus
acids such as deox~ribonucleic acid (DNA),
other disadvantages (such as expensive manufacturing
ribOnucleic acid (RNA) and protein
acid (PNA) are 20
uncertainty in the number of fragments per pixel,
fundamental components of matter of living organisms.
etc,),
Nucleic acids generally speaking consist of certain constituent parts, or base pairs. The permutations in which these
SUMMARY OF THE INVENTION
base pairs may be arranged is vast. Nucleic acid sequence
It therefore is an object of this invention to provide
analysis, i.e., determining the identity and sequence of the
base pairs of a nucleic acid sample, is an important tech- 25 methods and products for detecting the hybridization state of
a nucleic acid molecule, without needing to tag the sample.
nology. Deciphering nucleic acid sequences is important for
The invention can be used to perform sequence analysis of
disease diagnosis, drug design and understanding of various
unknown nucleic acids, such as DNA sequences. Several
biological mechanisms. Before 1996, traditional methods
genes can be probed simultaneously. Sequencing according
laboriously ''reap the gene sequencing one base pair at a
30 to the invention is relatively simple and quick, while protime.
viding precise and accurate sequencing information. The
~~~~~d 1996, mymetrix developed a massively
invention provides a bio-chip and other products for simulsequencing approach, using a DNA chip with which several
taneously analyzing one or more specific nucleic acid fragbase pairs can be read simultaneously. A monolayer of
specific single stranded DNA (ssDNA) fragments is 35 ments (such as genes) in a
In order to accomplish these and other objects of the
assembled on an array of pixels (-1-100,um2). The type of
invention, the present invention in a preferred embodiment
ssDNA may change from pixel to pixel. These ssDNA
provides a tagging-free method to detect binding of
fragments act as "chemical tweezers" to pick the specific
molecules, comprising the steps of: (A) providing a sensor
complementary tagged ssDNA from the sample to form
double stranded DNA(dsDNA), i.e., a hybridization process 40 comprised of a first layer including a single stranded nucleic
occurs. The hybridized region is observed by a fluorescent
acid sequence and a second layer including a photolumilabel applied to the DNA in the sample before exposure to
nescent material; (B) exposing said sensor to a biological
the ssDNA probe fragments. The process is speedier than
sample for sufficient time for said single stranded nucleic
single-base-pair methods, is specific, can analyze multiple
acid sequence to bind to a material of interest in said
nucleotide sequences, simultaneously can process hundreds 45 biological sample; (C) exposing said sensor to light and
of gene sequences and their alterations, and uses advantameasuring photoluminescence from said sensor. In a pargeously small chips. Practical applications of the parallel
ticularly preferred inventive tagging-free method, the measequencing technology include: Affymetrix' study of p53
suring step includes sensing photoluminescent light from the
gene malfunction (i.e., mutation) responsible for cancer
second layer when ultraviolet light with wavelength in the
range of 200-700 nm is applied to the first layer. In an
(especially breast cancer); Merck's study of changes in DNA
sequencing as the cell beings to rapidly proliferate (to
especially preferred embodiment, the wavelength of the
understand tumor formation); Incyte Pharmaceutical's
ultraviolet light applied is in the range of 2 6 e 2 6 5 nm. In an
disease-specific chips for drug design. Also, massively
especially preferred embodiment, the first layer is positioned
parallel, quick, sensitive and accurate bio-chip methods may
on a first side of the second layer, and said measuring step
,, measures photoluminescence from a second side of said
boost the Human Genome Project.
H
~ mymetrix>
~
approach
~
~tags unknown
~
to-be~
, second layer. In a further embodiment, said second side is
opposite said first side on said second layer. In another
sequenced DNAwith a fluorescent dye-altering the sample
embodiment that is preferred, said first layer is positioned on
so that it generally cannot be reused for other tests, d s o ,
a first side of said second layer, and said measuring step
because the Affymetrix chip at each pixel has about at least
a 5% error margin, the chip includes many repeated pixels, 60 measures photoluminescence reflected from said first side of
said second layer.
to manage the error margin. The fabrication process for
Affymetrix' chip is expensive, requiring lithographic techIn another preferred embodiment, the invention provides
nique.
a tagging-free sensor comprising a first layer including a
single stranded nucleic acid sequence and a second layer
DNA sequencing and other protein identification
techniques, especially speedy parallel approaches, have 65 including a ~hotoluminescentmaterial.
important practical applications, such as disease diagnosis,
In another preferred embodiment, the invention provides
drug design, genetic and cancer screening, deciphering and
an apparatus for tagging-free detection of binding of
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molecules, comprising: a light source; a sensor having a
said matrix material. In an especially preferred embodiment,
the second layer comprises polystyrene. In an especially
nucleic acid layer and a photoluminescent layer; and a
preferred embodiment, the second layer comprisesphotoluphotoluminescence detector. In especially preferred
minescent particles in a polymer matrix. In a further Preembodiments, the light source is an ultraviolet light source,
an infrared light source, or a visible light source. In other s ferred embodiment, the ~hotoluminescentparticles may be
Or u n d O ~ e d
the group
especially preferred embodiments, the detector is a light
consisting of group 11 and group VI. In another preferred
detector in the infrared to ultraviolet range. Where an
embodiment, as such a compound is wed doped Or undoped
ultraviolet light source is used, the ultraviolet light source in
zinc sulfide. Another especially preferred embodiment is one
a particularly preferred embodiment provides ultraviolet
in which the second layer comprises a nanocomposite. In a
10
light at a range of about 260-265 nm.
further preferred embodiment, the second layer comprises a
In
preferred
the
provides
thin-film or a support, In another preferred embodiment, the
a
making a tagging-free
second layer comprises a polymer, In another preferred
contacting a single stranded nucleic acid sequence with a
embodiment, the second layer has fluorescence when
photoluminescent material. Aparticularly preferred embodiexcited by light with a wavelength in the 200-700 nm range,
ment of such an inventive method includes devositinp. 1s
BRIEF DESCRIPTION OF THE DRAWINGS
photoluminescent material on a substrate to form a surface,
and thereafter modifying the surface by ion exchange treatThe foregoing and other objects, aspects and advantages
merit with a metal salt, followed by ion-embedding, folwill be better understood from the following detailed
lowed by exposing the ion-embedded material to reactive
description of the preferred embodiments of the invention
media to form photoluminescent particles.
20 with reference to the drawings, in which:
FIG. 1is a flowchart depicting a method according to the
In the above-mentioned methods, products and
apparatuses, a particularly preferred embodiment of the
present invention.
invention uses DNA, RNA andlor PNA as the single
FIG. 2(a) is a cross-sectional view of a device according
to the invention,
stranded nucleic acid. In an especially preferred
embodiment, the first layer comprises an ssDNAmonolayer. 25
FIGS, 2(b) and q c ) are enlarged views of part of FIG,
1n a ~ a r t i c u l a r l ~referred embodiment, the sensor corn2(a), with FIG. 2(b) showing unbound single stranded
prises ssDNA as said first layer grafted Onto the
nucleic acid material according to the invention and FIG.
layer.
2(c) showing bound nucleic acid material according to the
In a preferred embodiment, the nucleic acid sequence is 30 invention.
between 5 and 200 base pairs. In an especially preferred
FIGS. 3(a), (b) and (c) together are a series of crossembodiment, the sequence is about 25 base pairs. Another
sectional views showing probing according to the invention.
particularly preferred embodiment provides a discontinuous
FIGS. 4(a), (b), (c) and (d) depict device fabrication with
first layer comprising different nucleic acid sequences in
nanocomposite formation according to the invention,
different sections of said first layer.
FIG. 5 shows an Atomic Force Micrograph of a nano35
Further, another preferred embodiment of the invention
compos~testructure according to the invention,
provides a tagging-free method to detect binding of
FIGS, 6(a) and 6(b) show an optical micrograph of a
antigens,
the steps
(A) providing a
selectively modified polystyrene surface according to the
comprised of a first layer including an antibody and a second
invention,
layer including a photoluminescent material; (B) exposing 40
FIG. 7 shows fluorescent spectra from polystyrene used in
said sensor to a biological sample for suficient time for said
a photoluminescent-polymer containing embodiment of the
antibody to bind to an antigen of interest in said biological
invention.
sample; (C) measuring photoluminescence from said sensor.
a monolayer
P
~
~
Y
~
~
In a particularly preferred embodiment, the first layer is
block
copolymer
spheres
on
an
exemplary
silicon
surface
discontinuous and comprises different antibodies.
45 according to the invention.
In another preferred embodiment, the invention provides
an apparatus for tagging-free detection of antibody binding,
is a graph etching
polybutadiene as
comprising: a light source; a sensor having a first layer
a
time for an
cO~O1~according to the present invention.
including an antibody and a second photoluminescent layer;
FIG. 10 is a graph of the effect of surface treatment on
and a light detector.
Additionally,
preferred embodiment of the invenwater, for
lo
the present invention.
tion provides a tagging-free sensor comprising a first layer
FIG. 11is a field emission micrograph of ZnS nanoparincluding an antibody and a second layer including a photicles On a
toluminescent material. In a particularly preferred
embodiment, the first layer is discontinuous and comprises 55 according the present invention.
FIG. 12 shows ~hotoluminescencespectra for ZnSdifferent antibodies. In another especially preferred
containing materials according to the present invention.
embodiment, different known antibodies are included.
FIG. 13 shows a top view of a bio-chip according to the
Further detailed embodiments of the above-mentioned
invention
inventive methods, products and apparatuses are as follows.
FIGS. 14(a), (b) and (c) are a series of ~ross-sectional
Another particularly preferred embodiment of the inven- 60
drawings showing fabrication of a polymer blob1
tion in the second layer uses aromatic polymers, doped or
nano~articleanbodiment of the invention.
undoped metal oxides, sulfides, selenides, arsenides,
FIGS. 15(a)<g) show an exemplary process flow for
tellurides, andlor nitride and phosphide nanocomposites. In
making a nanoparticle array according to the invention.
another preferred embodiment, the second layer may comFIG. 16(a) shows an exemplary structure of a
prise a matrix material, with said photoluminescent material 65
associated with said matrix material. In a further preferred
nanoparticle/polymer blob bio-chip according to the invenembodiment, said photoluminescent material is embedded in
tion before use.

-
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FIG. 16(b) shows the structure of FIG. 16(a) after the
After the exposure procedure, an observation or measuresingle stranded nucleic acid has hybridized with a complement 200 is carried out, to observe or measure change (if
mentary base sequence to form a double stranded nucleic
any) in photoluminescence. For example, when providing
acid.
single stranded nucleic acid on a bio-chip, the bio-chip may
FIGS, 17(a)-(c) show a reading method according to the s be illuminated with light at a wavelength at which the single
stranded nucleic acid and the double stranded nucleic acid
invention for the device of FIGS, 16(~)-(b), in which uv
differentially absorb. Depending on what has occurred in the
light is incident at an angle on the sample and the luminesexposure process, no change 210 may be measured1
cent visible radiation from nanoparticles is recorded.
observed, or change 220 may be measuredlobserved. If no
DETAILED DESCRIPTION OF THE
10 change 210 is found, it can be concluded that the sample
PREFERRED EMBODIMENTS OF THE
lacks a sufficiently complementary material to bind to the
INVENTION
known single stranded nucleic acid sequence.
If change 220 is found, it can be ~ ~ n c l u d ethat
d a
In a first preferred embodiment, of which FIG. 1 is
sufficientlycomplementary material in the sample has bound
exemplary, the invention accomplishes nucleic acid (such as
DNA, RNA or PNA) or protein sequence analysis without 15 to the known single stranded nucleic acid sequence. From
tagging (such as fluorescent dye tagging), and provides
the identity of the known single stranded nucleic acid
products and apparatuses useable for such tagging-free
Sequence, the likely identity of the complementary bound
sequencing, ~ i ~ ofd molecules
i ~ ~ to a single stranded
material can be inferred. The amount of change 220 will
vary depending upon the degree of complementarity
nucleic acid sequence can be detected without using conventional tagging, ~h~ invention uses a material that is 20 between the single stranded DNA and the biological matephotoluminescent, which broadly includes a material that
rial. The change 220 is a function of the change in photoglows at any wavelength or that luminesces because of
luminesce that can be measured from a support underlying
photons. The invention uses application of light, and the
the single stranded DNA. As more and more biological
light input may be ultraviolet, visible, infrared or other light,
material from the sample is bound to the single stranded
25 DNA, greater and greater differences in the detectible lumiwithout limitation.
In an exemplary embodiment of such an inventive
nescence will result because of changes in the physical
tagging-free method, a single stranded nucleic acid material
characteristics of the nucleic acid between its single stranded
and bound state.
of known sequence is provided. Examples of the single
stranded nucleic acid material are DNA, RNA and PNA. The
In a preferred embodiment of the invention, a known
single stranded nucleic acid sequence may be of any length, 30 single stranded nucleic acid sequence is provided on a
with a preferred example being about 25 bp; however, the
substrate, probe, bio-chi~or other solid product, and the
single stranded nucleic acid could range from 5 to 200 bp.
biological sample is contacted in liquid form with the solid
As seen with reference to FIG. 1of an exemplary detecproduct. In other embodiments of the invention, the
may be
tion system according to the invention, a measurement or
unknown Or tO-be-sequenced
observation 100 optionally may be made for a known single 35 provided 011 a substrate, probe, bio-chip or other solid
stranded nucleic acid, alone. A numerical measurement is
product and contacted with a liquid probe comprising sensor
not necessarily required, and a baseline measurement in the
particles each
a
sing1e stranded nucleic
acid sequence attached to a photoluminescent material.
nature of a calibrating measurement or observation is within
The inventive methods and products may be used to
the present invention. The present invention is based on 40
sequence nucleic acid molecules (such as DNA, RNA or
differential (rather than absolute) measurements or observaPNA) or other proteins. For example, one or more specific
tions. In some embodiments, measurement or observation
DNA fragments (i.e., a gene) of unknown identity and
100 may be eliminated.
Sequence may be analyzed. The source materials for a
After measurement/observation 100, the known single
stranded nucleic acid sequence is then exposed to a biologi- 45 biological sample to test are not particularly limited and may
cal sample, such as a sample containing biological material
be any nucleic acid or protein-containing biological materials (such as blood, tissue, fingernail clippings, etc.). ~ a w
for which information is desired as to whether material
complementary to the known single stranded nucleic acid
biological material, such as blood, generally may be Prosequence is contained therein. For example, the sample may
cessed into testable fragments and Put into solution by
in the art.
comprise denatured DNA, RNA or PNA of unknown iden- so
The
single
stranded
nucleic
acid
sequence used in the
tity.
present invention is not particularly limited in the form in
F~~contacting the sample with the single stranded nucleic
which it is used, and a form such as a monolayer may be
acid, known methods may be used, such as providing the
used. A monolayer is particularly preferred.
single stranded nucleic acid on a bio-chip and pipetting a
small amount of the sample solution into a well in the ss
In a preferred embodiment, the single stranded nucleic
bio-chip. The conditions of contacting the biological sample
acid of the present invention is attached to a photolumineswith the known single stranded nucleic acid material are
cent material. A preferred example of the attachment is by
those permitting binding of the known single stranded
grafting. "Grafting" may include covalently bonding a pornucleic acid material with at least one protein or nucleotide
tion of the single stranded nucleic acid to the photolumiin the biological sample to form a complex, such as hybrid- 60 nescent material (e.g., by an amine linkage from lysine or
izing conditions. Hybridizing conditions are known to those
histidine), or it may include physical adsorption on the
working in the art. Upon such exposure of the known single
photoluminescent material, or other joining mechanism that
stranded nucleic acid sequence to the biological sample,
associates the single stranded nucleic acid and the photolubinding, hybridizing and formation of a complex occur if
minescent material in a manner which leaves a portion of the
complementary material is contained in the biological 65 single stranded nucleic acid free to bond to other biological
sample. Software is known to optimize hybridizing
materials of interest. Examples of the photoluminescent
conditions, by varying temperature, salt concentration, etc.
material include, without limitation, an optically active thin
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film, aromatic polymers, matrix materials that include metal
luminescent at the excitation wavelength. FIG. 2(b) shows
an enlarged view of part of FIG. 2(a), showing each single
oxides or sulfides such as ZnS doped with Mn, etc.
stranded nucleic acid sequence 3a of which layer 3 is
By way of non-limiting example, in an embodiment in
comprised. In one example of using a device according to
which a single stranded nucleic acid monolayer is grafted to
an optically active thin film, when the single stranded 5 the invention, and with reference to FIG. 2(c), the device is
exposed to biological sample material complementary to
nucleic acid monolayer is exposed to light, the amount of
single stranded nucleic acid layer 3 such that conversion of
emitted light from the attached optically active thin film
single stranded nucleic acid sequences 3a to a double
depends on absorption by the single stranded nucleic acid
stranded nucleic acid form 33 occurs by binding with a
layer. When the single stranded nucleic acid layer comes in
contact with a complementary molecule, the single stranded lo complementary sequence 3b in the sample, leading to
nucleic acid layer binds to the complementary molecule,
change in input (i.e., excitation) light incident into the
particularly, s
s converts
~ to d~ s ~~~h~~ binding
~ , of the
photoluminescent layer. The change in the incident light to
the ~hotoluminescentlayer occurs due to the change in
single stranded nucleic acid causes the intensity of fluoresreflectivity, absorption and scattering in the DNA layer as it
cent emission from the attached photoluminescent material
converts from single stranded to double stranded. Thus, as a
to change, Where ssDNA is used as the single stranded
l5 result of the binding that is conversion from single stranded
nucleic acid sequence, the observable fluorescence intensity
to double stranded causes a change in the emitted photolufor ssDNAversus dsDNA differs (because the absorption of
minescent light intensity, This change in intensity of the
is higher than dsDNA) in the 260 nm range.
emitted photoluminescent light may be recorded, such as by
rescence intensity is higher for the bound form (such as a
a confocal microscope via a CCD camera, or by fiber-optics,
converted dsDNA form) and this fluorescence intensity can 20 when an integrated optics approach is used, on-line meabe observed to confirm the Presence of the complementary
surement may be done during the hybridization process in
sequence in the sample being tested.
solution. On-line embodiments of the invention may be used
to probe several genes simultaneously.
For preferred materials according to the invention, e.g.,
polystyrene as the photoluminescent layer attached to
In a preferred embodiment, an example of using a device
ssDNA, the change in intensity of the photoluminescence 25 according to FIG. 2(a) is to provide ssDNA of known
when the ssDNA converts to dsDNA differs by only about
sequence as the single stranded nucleic acid on the device
2-4%, so that studying the intensity would not be particuand then to immerse the device in a solution of various
larly dramatic. However, the present inventors have made
unknown nucleic acid fragments. If there is a complementhe important recognition that at 2 6 e 2 6 5 nm, not only the
tary pair in the solution to the ssDNA on the device,
absorption changes, but the refractive index changes, 30 hybridization will occur, and the ssDNA layer on the device
will convert from ssDNA to dsDNA. The invention permits
because of which, the reflection (reflectivity) changes. The
amount of light reaching the polystyrene attached to the
probing whether such a
ssDNA dsDNA
has
to determine if the particular gene
DNA may change by as high as ZOO%, for the following
(complementary to known ssDNA on the device) exists in a
reasons.
biological sample solution. After reading the photoluminesDNA absorbs generally in the 260-265 nm range 35 cence for the device contacted with the sample, any bound
and shining such
On an
materials from the sample can be loosened using techniques
single stranded nucleic acid top layer results in absorption,
known to those skilled in the art, and used in other testing
reflection and scattering of the radiation. The left-over
applications,
transmitted radiation travels into the photoluminescent
probing according to the invention is a measurement of
material (such as polystyrene) causing it to give out radia- 40 change in photoluminescent light, as generally shown in
tion at a different wave length. For example, the ~hotolu- FIG. 3, which relates to absorption for an inventive method
minescence in polystyrene is at about 325 Dm. However, if
according to FIG. 1 or inventive device according to FIG.
the single stranded nucleic acid is bound SO that it becomes
2(a). With reference to FIG. 3,10 is the intensity of incident
double stranded, the nucleic acid now absorbs, scatters and
UV light at wavelength 265 nm (which is nominally the
reflects a different amount of excitation wavelength, so that 45 absorption maxima of DNA). As the UV radiation is
the amount of radiation experienced by a photoluminescent
absorbed by the layer of photoluminescent material 2, the
underlying layer differs from the case before binding
photoluminescent particles emit visible light of intensity I,,
occurred. Correspondingly the photoluminescent material
I, or I, (which represent output intensity with no DNA graft
(i.e., DNA immobilized on the surface by at least one
gives out different photoluminescence intensity. The refractive index changes, because of which, the reflection so covalent bond). If AI=I,-I, can be measured, the occurrence
(reflectivity) changes. The amount of light reaching the
of any hybridization reaction can be determined. The meaphotoluminescent material underneath may change by 200%
surement of A1 can be performed in-situ in the solution
or more. This is primarily due to the refractive index
because the attenuation of I, due to absorption by the
changes, because of which, the reflection (reflectivity)
solution is constant and absorption by DNA and solution in
changes, resulting in significant change with respect to the 5s the visible range is negligible.
excitation light into the photoluminescent layer. Thus, studyProbing is depicted in FIGS. 3(a), (b) and (c), for the
ing the amount of light from the photoluminescent material
device shown in FIG. 2(a), in a fiber optics mode. I, in FIG.
attached to the nucleic acid sequence provides a
3(a) is the photoluminescent intensity from optically active
dramatically-different result for unbound versus bound
layer 2 which in this example is a nanocomposite for
nucleic acid sequences.
60 incident UV radiation, 10. The output intensity is reduced to
Part of a bio-chip device that is an exemplary form of the
I, on deposition of ssDNA3 (FIG. 3(b)) that further reduces
UV radiation intensity incident on the optically active layer
invention is shown in FIG. 2(a). The device of FIG. 2(a), in
which optically active layer 2 comprises a photoluminescent
2 which is a nanocomposite. The intensity is further reduced
material such as a nanocomposite or a photoluminescent
when the ssDNA 3 is hybridized to form dsDNA 33 (FIG.
polymer, may be used as follows The nanocomposite which 65 3(c)). The resultant photoluminescent intensity for the
is a photoluminescent material may be provided in a matrix
device according to FIG. 3(c) is I,. The relevant signal is
AI=12-I,.
material, with the matrix material optionally being photo-
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The device of FIG. 2(a) optionally contains a reflective
The single stranded nucleic acid in a preferred example
layer such as gold layer 4 to enhance reflection, depending
according to the invention is provided directly or indirectly
on the end use. An optional reflective layer is preferably
on a substrate 1(FIG. 2(a)), the substrate not being particucomposed of a non-oxidizing material, of which gold is a
larly limited. A reflecting or nonreflecting substrate may be
preferred example. For example, as shown in FIG. 2(a), in s used, with a nonreflecting substrate being preferred. The
the reflection mode, a layer of reflective gold 4 deflects the
substrate 1 is not particularly limited and may be selected
visible light produced by the photoluminescent material on
based on the end-use probe method, A substrate is not
the top side of the device. In the transmission mode
required to be used in the present invention,
(primarily for device characterization), the gold layer 4 of
FIG, q a ) may be omitted and the visible p~oto~um~nescent The photoluminescent material used in the invention is
light may be detected on the other side of the sample, F~~the 10 one which allows for observing the differential optical
fiber optics mode, the gold layer 4 is not needed.
activity when the DNA layer changes from single to double
stranded nucleic acid sequences attached thereto. The phowill be appreciated that sequencing according to the
toluminescent material for use in the present invention is any
invention may be accomplished without any tagging of the
material that has different optical behavior when the single
D N A be
~ tested,
~
hi^ no-tagging feature will allow probing
"beforen and "after" structure of DNA when subjected to a 15 stranded nucleic acid sequence attached thereto is unbound
stimulus. For example, mutation of a gene due to UV
or bound. Examples of such photoluminescent materials are
radiation can be analyzed by the disclosed DNA chip. A
aromatic molecules, such as polystyrene or other polymers
probe according to the invention can probe kinetics of the
(all aromatic polymers will exhibit photoluminescence). The
mutation processes, location of the mutation and, imporphotoluminescent material used in devices according to the
tantly (in the presence of a drug) evaluate the role of the 20 present invention obviates the need for photoluminescent
drug-action on inhibition or acceleration of certain mutation
tagging of biological sample material, The photoluminesprocesses.
cent material (such as a polymer) to be used in the invention
In an alternative embodiment, on-line integrated optics
is selected so that when coupled with a single stranded
may be used for DNA sequencing according to the invennucleic acid and its double stranded nucleic acid, different
tion. 1n such a configuration, the device may be immersed in 25 photoluminescence is observed. Preferred photoluminescent
a solution to measure both the identity of a specific gene
materials are those which permit measurement of change in
sequence and its hybridization kinetics.
optical properties (i.e., complex refractive index) of the
The
in a further
may be
DNA as it changes from single to double stranded based on
probe DNA
and
physical Or
intensity of fluorescent emission from the photoluminescent
treatment, which may be particularly
for drug design 30 material attached to a nucleic acid, A preferred example of
applications.
a photoluminescent material for use in the present invention
In
DNA gene sequencing
and
is polystyrene, In the case of polystyrene coupled with
other above-mentioned applications, other uses of the phodsDNA or ssDNA, the absorption of ssDNA is higher than
toluminescent embodiments of the invention include applidsDNA in the 260 nm range, as may be observed from
cations that may not be possible for devices using tagging
35 intensity of fluorescent emission.
methods. Further, because probes according to the invention
The ~hotoluminescentmaterial may be a nanocom~osite,
may be large area devices, they may be used to separate
a thin film loaded with sub-micron to nano-scale photoluknown sequences from a mixture of single-strand nucleic
acid fragments at high precision and sensitivity, B~~~~~~ minescent particles, photoluminescent particles present in a
sensors according to the invention may be made on-line,
polymer matrix, Or any
form
photoluminescent
sensors according to the invention have applications as 40
A nanocomposite for use in the invention preferably
on-line sensors for PCR.
comprises a polymer matrix encapsulating ~hotoluminesDevices comprising known single stranded nucleic acid
cent particles. The polymer matrix encapsulating the phosequences for use in practicing the invention may be easily
fabricated, such as by the method shown in FIGS, 4(a) 45 toluminescent particles preferably is non-wetting such that
through (d), ~~~~~l~~ of a device according to the present
no nucleic acid adsorption other than the intended nucleic
acid attachment Occurs.
invention are a probe, a bio-chip, and other products useable
However, the surface may be selectively modified to
in tagging-free sequencing.
allow for controlled nucleic acid grafting where the density
F~~use in the present invention, known single stranded
nucleic acid sequences of length may be used, with so of molecules per unit area can be regulated. The attachment
density preferably is low enough to avoid entanglement of
sequences of length from about 5 bp to about 200 bp being
adjacent chains and to allow for enough chain mobility for
preferred, and a sequence of about 25 bp being most
fast hybridization kinetics in solution. Preferably the density
preferred.
should be high enough for large change in complex refracTo make an exemplary device according to the present
invention, a single stranded nucleic acid sequence 55 tive index of the nucleic acid layer as it changes from single
stranded to double stranded. Polystyrene is an example
(preferably of known sequence) may be attached to a phomeeting these criteria.
toluminescent material. Attachment techniques for nucleic
Preferred production methods for making devices accordacids are known to those skilled in the art, including, without
ing to the present invention include nanocomposite produclimitation, grafting, immobilization, electrovalent
attachment, covalent attachment, adsorption, van der Waals 60 tion procedures, self-alignment production procedures,
nano-particle nano-array fabrication, and polymer blob/
attachment, etc. A preferred attachment mechanism is to
nano~articlefabrication.
covalently attach the nucleic acid sequence to the photoluminescent material. The attachment may be to directly attach
An example of a nanocomposite production method is as
the nucleic acid to the photoluminescent material or may be
follows. As shown in FIG. 4(a), a nanocomposite film is
to indirectly attach the nucleic acid to the photoluminescent 65 deposited on a rigid substrate (such as quartz or glass). To
material, such as by interposing a linker or adhesion prodeposit a smooth nanocomposite film shown in FIG. 4(b), an
moter.
in-situ three-step procedure is used, in which surface modi-
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fication is followed by ion exchange with an appropriate
In an embodiment in which a nanocomposite is used as
metal salt. Next, the ions are subsequently embedded and
the optically active layer 2, nanocomposite is formed on the
then exposed to reactive media to form photoluminescent
substrate. With reference to FIG. 1,ssDNA3 is grafted onto
particles. During the ~article-embedding,the polymer surthe nanocomposite. Preferably, the nanocomposite surface
face is regenerated. The resultant structure is shown in FIG. 5 has been modified to allow for selective grafting thereon of
4(b), with
an
ssDNA. The selective modification makes possible fabricat(AFM)
a nanOcOm~Osite
structure
ing a chip with large combinatorial of ssDNA that can be
4(b) and according to the invention. The surface studied is
used with simple micropipette dispensing,
1 by 1pm in tapping mode where both the topography (i.e.
contrast is height) and damping (i,e,, contrast is local
After any
pre-grafting surface
the
ssDNA3 layer is grafted, such as
an
hardness) are mapped. Comparing the three types of samples
clearly indicates that the particle are formed and the embedlinkage, such as difunctionalized organic compounds where
One end
react with a (surface
polystyrene
ded particles are smaller than when the sulfonation takes
surface and the other end will attach to the 3' or 5' end of the
place without any diffusion of ions in the bulk, ~h~ fact that
SSDNA.Examples of such organic compounds are commerthe contrast is weaker for the embedded samples in the
cially available from Sigma Chemical Co. (St. Louis, Mo.1
damping-map indicates that the particles are diffused inside
and Molecular Probes, Inc. (Eugene, Oreg.).
and the surface is nominally all polystyrene.
Preferably the functional groups are highly polar to
Returning to the operations of FIG. 4, the regenerated
achieve selectivity. By functionalizing discrete regions of
surface (such as a polystyrene surface) shown in FIG, 4(b)
the polymer surface, the ssDNA can be grafted l lo call^"
next is selectively modified. The modification process preferably is one that (i) is selective; (ii) permits the density of 20 confined to these regions. Preferably these regions are about
functionalities on the surface to be regulated; and (iii)
100 by 100 microns so that it will be convenient to microprovides a functionality such that the 31 or 51 end ofthe DNA
pipette different ssDNAsequences in different surface modican be grafted. Simple plasma surface modification and
fied regions. Thus an array of known ssDNA of various
standard wet-surface modifications are known to those
sequences can be deposited on the substrate 1.Because the
skilled in the art, and either modification procedure may be 25 functionalized surface is highly polar and the polymer (such
used as a surface treatment in the present invention.
as polystyrene) is non-polar the DNA solution will self align
on ~the functionalized
regions due to surface tension.
~
~to FIGS,f 4(c) and~ 4 ( 4 , DNA
~ grafting
~ may bei
~
The ssDNA 3 that is grafted to the optically active
achieved by simple dispensing of ssDNA solution on the
functionalized area. As seen with reference to FIG. 6, the 30 polymer support is known. In a preferred embodiment, the
S S D N A consists
~
essentially of a monolayer of SSDNA.The
droplet placement of different ssDNA solutions will be
known, grafted SSDNA3 layer is available for binding with
self-aligning because the functional polar region is surmolecules in a sample, such as hybridizing with Unknown
rounded by non-polar area. FIGS. 6(a) and (b) are optical
ssDNA of a sample. The amount of emitted visible light
micrographs of a selectively modified polystyrene surface
according to the invention, The treatment time was 90 35 increases monotonically with the difference in reflectivity of
seconds to ensure full modification, The droplets were
the DNA layer as it changes from single to double stranded.
formed by immersing the sample in water and air blowing
The difference in reflectivity increases monotonically with
change in complex refractive index from ssDNA to dsDNA.
the excess water. The scale indicator is 1 mm.
With reference to FIG. 1, the completed structure is
The self-alignment property is important in lowering the
cost of device fabrication. For example, if 100x100 pm 40 composed of two active layers: the top layer of grafted
ssDNA3 over a nanocomposite which is the optically active
features at 1mm period are made on a 25x25 mm substrate,
layer 2 composed of photoluminescent particles. The nature
over 600 combinatorial can be simultaneously performed.
of the substrate 1and other structure depends on the end-use
Such deposition geometry can be performed by existing
probe method, such as reflection mode or transmission
dispensing systems common in microelectronics manufacturing or by micro-pipetting. The former is especially pre- 45 mode.
ferred because the process can be expedited to the order of
In an alternative embodiment of the invention, the opti600 depositions in less than 100 seconds, with reliability.
cally active layer 2 of the device of FIG. 1instead of being
FIG. 4 ( 4 shows the resulting surface with portions of two
a nanocomposite is a photoluminescent polymer. Such a
different types of ssDNA labeled ssDNA-1 and ssDNA-2.
device may comprise a two-layer structure of a monolayer of
FIG. 4 thus shows in-situ nanocomposite formation so ssDNA grafted onto a polymer thin film. The polymer thin
film may be one that is optically active such that it has
according to the invention, starting with a highly smooth
fluorescence when excited by radiation in the UV region,
polystyrene film deposited on a substrate. The film is then
preferably in the vicinity of 265 nm wavelength. For
processed in three steps to produce photoluminescent
example, the film may comprise polystyrene. The film may
particles, with ZnS:Mn particles produced. The surface is
regenerated to produce polystyrene at the surface. The film 5s be deposited on an appropriate substrate depending on the
is exposed to similar surface modification to functionalize
intended end-use of the probe application. When the device
the surface with acidic or basic moieties to attach to the 5'
is exposed to UV light (-265 nm wavelength), the photoactive polymer film will emit light and the device may be
or 3' end, respectively.
As shown in FIG. 2(a), onto a substrate 1 optionally there
used as set forth above for a device in which the optically
is provided a gold electrode 4. After forming the electrode 60 active layer 2 is a nanocom~osite.
4, a nancomposite comprising a polymer and photoluminesFIG. 7 shows typical fluorescent spectra from polystyrene
under various conditions, when used in a device according
cent particles is formed on the substrate 1 and electrode 4.
A solution of polymer and photoluminescent particles may
to the present invention. The dark curve with lower intensity
be used. As examples of the photoluminescent particles may
is the luminescence spectra of polystyrene coated with a
be mentioned particles that when exposed to UV light (about 65 monolayer of ssDNA. The signal is intensified as the ssDNA
265 nm wavelength), emit visible light (e.g., green), such as
is converted to dsDNA. The peak intensity increases and the
ZnS doped with Mn (i.e., ZnS:Mn).
peak position is red-shifted. The difference in the intensity of
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the fluorescent light before and after the conversion of
ssIlNA to dsDNA is defined as the contrast. The typical
contrast shown in FIG. 7 is significant to decipher the
ssIlNA to dsDNA transformation. This change in intensity
(i.e., contrast) of the emitted light may be recorded by s
several methods, such as (i) a confocal microscope via a
CCD camera; and/or (ii) a fiber-optic method. Afiber-optic
integrated optics approach will allow for on-line measurement during the hybridization process in solution.
Fabrication of a photoluminescent polymer-containing 10
device may be as follows. A surface modification method
may be used, to allow for selective grafting of ssDNAon the
polymer surface. Particularly, the selective modification
allows fabricating a chip with large combinatorial of ssDNA
using simple micropipette dispensing. With reference to 15
FIG. 2(a), the structure is composed of two active layers: the
top layer of grafted ssDNA over an optically active material
layer which in this embodiment is a fluorescent polymer
layer. The nature of the substrate and other structure depends
on the probe method. Two typical, but not limiting, probe 20
methods are: (i) in the reflection mode, there is a third layer
of reflective Au to deflect the visible light produced by the
~hotoluminescentmaterial on topside of the device; (ii) in
the transmission mode (such as primarily for device
characterization), the AUlayer is not included and the visible 25
photoluminescent light is detected on the other side of the
sample.
The photoluminescent polymer may be composed of a
fluroescent polymer or blend of a polymer with a photoluminescent dye. The ssDNA in the top layer are of known 30
sequence using an appropriate coupling linkage, such as
difunctionalized organic compounds where one end will
react with (surface modified) polystyrene surface and the
other end will attach to the 3' or 5' end of the ssDNA.
35
It is preferred that the functional groups are highly polar
to achieve selectivity. By functionalizing discrete regions of
the polystyrene polymer, the ssDNA can be grafted locally
confined to these regions. It is preferred that these regions
are about 100 by 100 microns making for ~ ~ n v e n i e n40t
micro-pipetting of different SSDNA sequences in different
regions. Thus an array of ssDNA of various sequences can
be deposited on the polystyrene substrate. Because the
functionalized surface is highly polar and the polystyrene is
non-~olar,the DNA solution droplets will self-align on the 4~
functionalized regions due to surface tension. FIGS. 6(a)
and 6(b) show such a surface modified polystyrene film
according to the invention. After immersing the film in water
only the modified area has a wetting characteristic.
Preferably, the polymer for layer 2 is selected to be so
non-wetting such that no DNA adsorption is possible.
However, selective modification of the surface may be used
to allow for controlled ssDNA grafting where the density of
molecules per unit can be regulated. Thus, even if a drop is
too big, the drop will confine itself to the selectively ss
modified area. The graft density preferably is low enough to
avoid entanglements of adjacent chains and to allow for
enough chain mobility to allow for fast hybridization kinetits in solution. Also, the density preferably is high enough
to result in a large absorption by the DNA layer. One 60
exemplary polymer that fits these criteria 1s polystyrene.
FIGS. 6(a) and 6(b) show selective modification of
polystyrene, with only the area exposed being wetting and
suitable for single stranded nucleic acid strands to graft
thereto.
65
Thus, a DNA chip according to the invention may be
fabricated using self-assembly techniques, which are less
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expensive than lithography used in traditional methods of
making DNA chips. Self-assembly is significantly less
expensive than traditional lithography-based DNAchip fabrication methods. The self-alignment property of ssDNA is
exploited, particularly, the functional polar region being
surrounded by non-polar area. A reliable and relatively fast
manufacturing process may be accomplished, with many
depositions per minute possible.
Another alternative for making devices according to the
present invention is to decorate nanoparticles on a block
copolymer template. A block copolymer comprising at least
two chain types is deposited on a substrate. The deposition
is performed either by a solution process or a solid-forming
process. The block-copolymer film is thermally processed to
separate the nanophase into discrete phases of the minority
polymer. The structure of the discrete phase may be nanospheres or cylinders with nano-scale diameter or other
(more) complex geometries depending on constituents of the
block copolymer. The important property of the film is a
structure with phase-separated regions with characteristic
dimensions in the 5-500 nm scales.
~
~ the ~blockt copo~ymer
,
is subjected to a surface
treatment that etches the surface to expose the discrete phase
and in the same process activates the surface of the discrete
phase. However, the etched "rnatrixn polymer is not activated. Subsequently, the structure is exposed to precursor
solution of inorganic and/or organo-metallic salts in a solvent system that does not attack the block copolymer. The
salt(s) react with the activated surface to form a selective
deposition on the exposed surface of the discrete phase.
Next, the deposited salt is reacted either with a reactive
gas or an active solution to form nanoparticles that are
specifically confined to the discrete phase regions. The
sample optionally may be annealed before or after the
nanoparticle synthesis step. Annealing embeds the resultant
nanoparticles in the discrete phase. The resultant structure is
defined as polymer blobs with nanoparticles.
FIG. 1 4 shows a schematic of an exemplary process flow
to make a chip according to the invention. Polymeric
"blobsn 6 ranging in size from about 1&1000 nm are
produced on a substrate 1. The blobs may be on a random or
periodic array (see FIG. 14(a)). Subsequently a single
stranded nucleic acid molecule 3a is attached (such as by
grafting) to each blob 6. Depending on the size of the blob
and the number of bases in the nucleic acid sequence 3a, the
number of nucleic acid sequences 3a per blob 6 may range
from about 1 to 10, F~~ blob diameters below 50 nm and
nucleic acid molecules having more than 80 bases, the
number of nucleic acid molecules is likely to be one per
blob.
FIGS, 15(~)-(~)show an exemplary method of fabricating a nucleic acid
according to the invention,
FIG,
15(a) shows, as starting materials, on a substrate 1 is
provided a block copolymer 8 in which one of the blocks 8B
is a diene polymer that may be etched by an oxidation
process such as ozone or oxygen plasma. The other polymer
segment 8 ~an ozone
i ~ resistant polymer, polymer segment
8B is the majority phase and polymer segment 8A(shown as
spherical) is the minority phase. The composition is such
that the minority phase 8 A separate to form spheres or
sphere-like particles. It is preferred that the block copolymer
8 is fairly monodispersed to have the spheres self assemble
in a nominally regular lattice.
an example, minority phase
polymer segment 8 A may be polystyrene (PS) or poly
(methyl methacrylate) (PMMA) and majority phase 8B may
be polyisoprene or polybutadiene.
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In FIG. 15(b), the block copolymer thin film 8 is spin cast
Using any of the above-mentioned production methods,
and annealed to form a monolayer of the microphase sepaor any other suitable method, a bio-chip such as that of FIG.
rated spheres. Then the matrix is etched by ozone or plasma
1 3 with an array of pixels 5 may be made. In a preferred
to form isolated A-spheres 8a. Subsequently the sphere 8a is
embodiment, the invention provides a DNA chip for phoannealed above the glass transition temperature of the ~ 0 1 ~5 - toluminescent measurements at lo4 pixels (sites). The same
mer form polymer
(see
15(~)).In the next
pixel may be repeated 100 times, at different locations, so
that repeated measurements may be made, to establish
step, the surface l a of the substrate 1is modified by anionic
groups (see
15(d))
provide
88a. The
statistical significance. For example, a lo4 pm2 size probe
group used for such modification may be a strong anion that
with
shown, for example, as in FIG, 16(a) may be
forms a
when
an
Zn, Cd,
fabricated, Each substrate may have a different single
Pb or Hg salts. Upon annealing (see FIG. 15(e)) to form 10
stranded nucleic acid probe. The UV light input and visible
annealed blobs
and exposure to H2S, II-VI calcogenid
light Out may be
in to the substrate
a
nanoparticles 9 will be formed (see FIG, 1 5 0 ) in the blobs
optical method, known to one skilled in the art.
sac, T~ provide the highest p~oto~uminescence,a typical integrated
For example, optical fibers may be used. To improve the
nanoparticle may be doped, such as, ZnS:Mn or ZnS:Ag.
signal to noise ratio the incident beam may be n~odulated
The former has highest photoluminescence intensity around
and the output signal may be locked-in at the same fre265 nm which is close to the maximum absorption of nucleic
quency. Such an integrated approach advantageously builds
acids in the UV-region.
a" on-line sensor where each fiber or fiber bundle has a type
In the next step, the blob surface is modified again by wet
of single stranded nucleic acid different from the other fiber
chemistry, plasma or corona to form moieties that can react
bundle. In this way, several single stranded nucleic acids
with the 3, or 5, end of the nucleic acid chain, F~~example,
if a hydroxyl group is formed by water plasma, the phos- 20 may be probed in a mixture simultaneously, such as in a
multi-gene probe.
phate end will react to form a covalent bond. Thus the
A"digital" approach may be used in fabricating a bio-chip
nucleic acid chain will be grafted on the polymer blob
according to the invention, in which the probe sites are
surface. Depending on the size of the nucleic acid, one or
arranged on a periodic array with 1@50 nm scale periodmore chains can be grafted per blob. For a long chain over
50 bases, only one chain may be grafted per blob due to the 25 icity. A discrete, periodic arrangement will allow for absolateral size of the chain (see FIG. 16(a) which is an enlargelute nucleic acid count with high sensitivity and accuracy,
ment of FIG. 15(g)). FIG. 15(g) and FIG. 16(a) show a final
and low noiselerror that otherwise arises due to overlap of
structure with a nanoparticle 9 in a blob 88d and the single
signals from adjacent fragments in an "analog" method.
Compared to conventional bio-chip technologies, the invenstranded nucleic acid 3a graft. When such a surface is
exposed to a mixture of single stranded nucleic acid 30 tive methods and products are useable with sample sizes
lo3-lo4 smaller. Also, the array fabrication may be based on
fragments, the probe single stranded nucleic acid grafted on
a relatively inexpensive and highly parallel self-assembly
the substrate will act like chemical tweezers to pick the
approach instead of expensive lithographic techniques.
complementary single stranded nucleic acid for hybridization. The resultant double stranded nucleic acid 33 on the
The present invention has been discussed above particusurface is shown in FIG. 16(b). Nanoparticles 9 generally 35 larly with regard to nucleic acids. Because the complex
have a diameter in the range of 2-30 nm. Blobs 88d
refractive index of the proteins also changes significantly in
generally have a diameter of about 10-100 nm and pitch
the UV range as it reacts with other proteins or alters
about 10-100 nm.
structure, a sensor or analytical device can be fabricated to
probe antigens and proteins as discussed above with regard
For a device such as that of FIGS. 16(a)<b), a reading
method may be provided as follows. The reading of the
to nucleic acids. Thus, an antigen-antibody sensor may be
hybridized sites indicating a match is explained in FIGS. 40 provided. In such a device, the desired antibody replaces the
17(a)-(c). When the chip with no nucleic acid is exposed to
single stranded nucleic acid. Because no tagging is required,
UV light (excitation light or probe light) the photoluminessuch a device can be a highly sensitive sensor to detect small
cent nanoparticles radiate I, in the visible range (see FIG.
levels of antigens and proteins that are airborne or in liquid.
17(a)). The visible light is equal in all directions. To avoid
The principle of detection and device fabrication is as set
any interference from the probe (i.e., UV) light, the lumi- 45 forth regarding the use of single stranded nucleic acids.
nescence intensity I, is recorded in the normal direction.
Non-limiting examples according to the invention are as
When the nucleic acid chip with single stranded nucleic acid
follows.
3a is exposed, the intensity changes from I, to I, because the
EXAMPLE 1
light incident on the nanoparticle changes due to change in
the optical property (i.e., absorption, reflectivity or 50
A block copolymer film of polystyrene (PS)/
scattering) of the top surface due to attachment of the single
polybutadiene (PB) was deposited on a silicon (Si) surface
stranded nucleic acid (see FIG. 17(b)). The intensity further
to produce a highly ordered discrete phase of PS spheres.
changes to If when the single stranded nucleic acid hybridSee FIG. 8. The structure was then exposed to plasma
izes to form double stranded nucleic acid 33 (see FIG.
containing water vapor to etch the butadiene and modify
17(c)). The change from FIGS. 17(b) to 17(c) is due to the 55 polystyrene. FIG. 9 shows a typical etch curve (for
polybutadiene) indicating the amounts of etch as a function
change in complex refractive index of DNA as it converts
of exposure time. To confirm that the surface modification is
from single to double stranded. Thus the amount of photoindeed selective, pure polymer PS and PB were exposed to
luminescent light from the nanoparticle will change accordingly in the three cases shown in FIG. 17. The contrast, 1,-1,
similar treatment. The wetting angle for water, in FIG. 10, as
a function of plasma exposure clearly indicates that PS is
is proportional to the number of single stranded nucleic acid
molecules per unit area. Hence a calibration of the sites 60 modified and becomes highly polar (i.e., wetting) however,
available for hybridization will be provided. The contrast
PB is not modified in any significant manner. Particularly,
IfIo=,AI is proportional to the number of single stranded
FIG. 10 shows that the contact angle of water decreases on
nucleic acids hybridized to double stranded.
PS but remains high for PB as the treatment time increases.
The production methods discussed above are by way of
The activated surface is immersed in Zn-salt solution and
example, and are not limiting. For example, where ssDNA 65 exposed to H2S to form ZnS. FIG. 11 shows a typical
is mentioned, the methods may be applied for other nucleic
field-emission scanning electron micrograph (SEM) where
acids.
the PS spheres are bright compared to the PB matrix. The
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brightness of PB is attributed to presence of high atomic
acid to bind to an untagged material of interest in said
biological sample;
number Zn compared to low atomic weight materials (i.e., C
(C) applying light to said sensor; and
and H) in the matrix. In FIG. 11, ZnS nanoparticles on a
block copolymer are shown, and notably the PS discrete
(D) measuring photoluminescence from said sensor,
wherein photoluminescence measured in said step of
islands are spherical and bright compared to the matrix 5
exposing is indicative of binding of said untagged
indicating that the ZnS is confined only to PS. The random
single stranded nucleic acid to said untagged material
arrangement of PS spheres is due to over-etching of PB.
of interest.
Photoluminescence (PL) spectra of the resultant sample
shown in FIG. 12, which shows photoluminescence from
2. The tagging-free method of claim 1, wherein the single
stranded nucleic acid is selected from the group consisting
znsparticles, indicate that the typical emission peak at -420
DNA, RNA and PNA.
nm is strongly blue shifted by over 100 nm indicating the
3. The tagging-free method of 'laim
wherein said
presence of nanoparticles of ZnS. The strong blue shift is an
second
layer
comprises
a
matrix
material,
with
said photoindication of quantum confinement effects indicating a
luminescent material associated with said matrix material.
nominal size of <3 nm ZnS particles.
4. The method of claim 3 wherein said vhotoluminescent
material is embedded in said matrix mat&ial.
EXAMPLE 2
5. The tagging-free method of claim 1, wherein the second
layer comprisespolystyrene.
Using self-assembled block copolymer monolayers and
6. The tagging-free method of claim 1, wherein the second
high anisotropic etching, a structure is made by grafting
layer
photoluminescent particles in a polymer
ssDNA fragments (x) on a nanoparticle coated polymer
blob. The blobs (made of polystyrene (PS)) are arranged 20 matrix.
7. The tagging-free method of
6, wherein the
periodically on a (silicon) substrate. The periodicity and size
photoluminescent particles are
Or u n d O ~ e d
of the blobs is in the 10-20 nm range (see FIG, 14(a)), The
pounds
from the group consisting of group and
direct band gap semiconductor nanoparticles are embedded
group "I.
in-situ in the polymer to ensure nominally monodispersed
size distribution and to simplify the process, The luminesThe tagging-free method of
7,
Or
cence excitation will be tailored to the maximum at -260 nm 2s undoped zinc
9. The tagging-free method of claim 1, wherein the second
(close to the absorption maxima of DNA), As the ssDNA is
layer
comprises a nanocomposite.
grafted, the luminescent light in the visible range will be
lo. The tagging-free method of 'laim
wherein said light
attenuated from I, to Ii, Thus by measuring the difference
is applied to said first layer of said sensor, and said light is
AI=IfIi as the probe sites with grafts are exposed to a
light with
in the range of 20e700
ssDNA mixture the amount of y fragments can be quanti- 30
tatively calculated. The calibration constant relating A1 and
The tagging-free method of
wherein the
number of y attached to the substrate is determined exactly
wavelength of the ultraviolet light is in the range of 26e265
since the number of sites are known, To achieve measurable contrast, i.e., AI-10% change, the minimum ssDNA
12. The tagging-free
wherein the first
size is a 50 base pair sequence, For 50 base sequence ssDNA 3s
layer comprises an
monolayer.
on 20 nm pitch array, only one chain per blob is possible due
13. The tagging-free method of 'laim
wherein the
to lateral size of the gaussian chain (see FIG. 14(a)). A total
second layer comprises a thin-fi1m Or a support.
array size of lo4pm2 is sufficient to measure I,, Ii and If for
14. The tagging-free method of 'laim
wherein the
nanoparticle monolayers with a conservative quantum efficiency of 25% and detector acceptance angle of 30". This 4o second layer comprises a polymer.
15. The tagging-free
wherein the
way, a sensitivity to measure 2,5x107 ssDNA (or -10
nucleic acid sequence is between 5 and 200 base pairs.
femotgram) per array is possible, By making an ensemble
16. The tagging-free method of 'laim
wherein the
with several arrays of different ssDNAgrafts and connecting
Sequence is about 25 base pairs.
each array to a 100 pm diameter optical fiber, a parallel
17. The tagging-free method of claim 1, wherein the
analysis of several fragments can be achieved.
4s second layer has fluorescence when excited by light with a
While the invention has been described in terms of its
wavelength in the 200-700 nm range,
preferred embodiments, those skilled in the art will recogla, The tagging-free method of claim wherein the
nize that the invention can be practiced with modification
sensor comprises ssDNA as said first layer grafted onto the
within the spirit and scope of the appended claims.
second layer.
We claim:
19. The tagging-free method of claim 1, wherein said first
l.Atagging-free method to detect the binding of untagged
layer comprises a plurality of sections each of which cornsingle stranded nucleic acid to an untagged material of
prises a different untagged single stranded nucleic acid
interest, comprising the steps of:
sequence.
(A) providing a sensor comprised of a first layer and a
20. The method of claim 1, wherein said first layer is
second layer wherein said first layer comprises an
positioned on a first side of said second layer, and said
untagged single stranded nucleic acid and wherein said ss measuring step measures photoluminescence from a second
second layer comprises a photoluminescent material,
side of said second layer,
and wherein said first layer and said second layer are
21. The method of claim 20, wherein said second side is
separate layers, and wherein said second layer cornopposite said first side on said second layer,
prises material selected from the group consisting of
22, The method of claim 1, wherein said first layer is
aromatic polymers, doped or undoped metal oxides, 60 positioned on a first side of said second layer, and said
sulfides, arsenides, tellurides, and nitride and phosmeasuring step measures photoluminescence reflected from
phide nanocomposites;
said first side of said second layer.
(B) exposing said sensor to a biological sample for
* * * * *
sufficient time for said untagged single stranded nucleic
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